Fineline Cube

Follow:
14422 Articles
Hengrui’s HRS9531 Injection Clears NMPA Approval, Hits 19.2% Weight Loss in Phase 3
CompanyDrug

Hengrui’s HRS9531 Injection Clears NMPA Approval, Hits 19.2% Weight Loss in Phase 3

Biocytogen, Merck Partner on Antibody‑Conjugated Lipid Nanoparticles
CompanyDeals

Biocytogen, Merck Partner on Antibody‑Conjugated Lipid Nanoparticles

Argo Biopharma, Novartis Expand siRNA Collaboration for Cardiovascular Drugs
CompanyDeals

Argo Biopharma, Novartis Expand siRNA Collaboration for Cardiovascular Drugs

ChemPartner & Toposcend Form $200 M Healthcare Fund to Back Innovative Drugs
CompanyDeals

ChemPartner & Toposcend Form $200 M Healthcare Fund to Back Innovative Drugs

AbbVie Secures NMPA Priority Review for Epcoritamab in Relapsed Follicular Lymphoma
CompanyDrug

AbbVie Secures NMPA Priority Review for Epcoritamab in Relapsed Follicular Lymphoma

Replicate Bioscience Teams With Novo Nordisk On srRNA‑Powered Metabolic Drugs
CompanyDeals

Replicate Bioscience Teams With Novo Nordisk On srRNA‑Powered Metabolic Drugs

Simcere Secures NMPA Approval for Deunoxavir Marboxil, First Pediatric Influenza Drug
CompanyDrug

Simcere Secures NMPA Approval for Deunoxavir Marboxil, First Pediatric Influenza Drug

FDA Unveils RDEP to Accelerate Rare Disease Therapy Development
Policy / Regulatory

FDA Unveils RDEP to Accelerate Rare Disease Therapy Development

Aosaikang Launches Phase III Trial of ASK202 with Leatinib for NSCLC
CompanyDrug

Aosaikang Launches Phase III Trial of ASK202 with Leatinib for NSCLC

Ab&B Bio‑Tech Wins NMPA Approval for First‑Ever Quadrivalent Influenza Subunit Vaccine
CompanyDrug

Ab&B Bio‑Tech Wins NMPA Approval for First‑Ever Quadrivalent Influenza Subunit Vaccine

Sanofi’s Tzield Earns China NMPA Approval for Stage 2 Type 1 Diabetes
CompanyDrug

Sanofi’s Tzield Earns China NMPA Approval for Stage 2 Type 1 Diabetes

Zenas Secures $300 M Royalty Deal for Obexelimab – Royalty Pharma to Invest
CompanyDeals

Zenas Secures $300 M Royalty Deal for Obexelimab – Royalty Pharma to Invest